Novel Systems for the Study of Human Disease : From Basic Research to Applications

Novel Systems for the Study of Human Disease From Basic Research to Applications

Transgenic mice have become of central importance for basic biological research, and for understanding diseases involving malfunction of the genetic machinery. The value of these animals as research tools may extend far beyond the purposes of the research project for which they were generated. Their...

Descripción completa

Detalles Bibliográficos
Autor principal: Organisation for Economic Co-operation and Development.
Autores Corporativos: Organisation for Economic Co-operation and Development (-), Organisation for Economic Co-operation and Development Content Provider (content provider), Organisation for Economic Co operation and Development Content Provider
Formato: Libro electrónico
Idioma:Inglés
Publicado: Paris : OECD Publishing 1998.
Colección:OECD proceedings Novel systems for the study of human disease
Materias:
Science and Technology
Genetics > Research > Congresses
Diseases > Congresses > Research
Biotechnology > Congresses
Transgenic animals > Congresses > Research
Biology
Health & Biological Sciences
Genetics
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009705298406719
Tabla de Contenidos:
  • EXECUTIVE SUMMARY
  • SCIENTIFIC SUMMARY
  • OPENING SPEECHES BY HOST COUNTRY
  • INTRODUCTION
  • Gene targeting: an historical perspective by M. Capecchi, United States
  • Somatic gene therapy: from basic science to clinical applications by S. Woo, United States
  • CURRENT DEVELOPMENTS IN THE TECHNOLOGY
  • -Conditional gene targeting by K. Rajewsky, Germany
  • Engineering chromosomes in mice to facilitate the identification of tumour suppressor genes by A. Bradley, United States
  • The use of genetic switches for the generation of conditional mutants at the level of cells and animals by H. Bujard, Germany
  • -Yeast Artificial Chromosomes as vectors for transgenesis by G. Schütz, Germany
  • We need more mutants: plans for a large scale ENU mouse mutagenesis screen by R. Balling, Germany
  • INTERNATIONAL FACILITIES AND INFRASTRUCTURE
  • The Jackson Laboratory: research to resource by B. Knowles, United States
  • The European Mouse Mutant Archive (EMMA) by P. Rigby, United Kingdom
  • Supporting transgenic research: repositories and distribution – the CDTA experience by C. Benoist, France
  • Rapid and efficient embryo manipulation systems by using cryopreserved mouse embryos, oocytes, and sperm" (Abstract) by M. Katsuki, Japan
  • GENERAL DISCUSSION SESSION I: CURRENT DEVELOPMENTS IN THE TECHNOLOGY and INTERNATIONAL FACILITIES AND INFRASTRUCTURES
  • FIELDS OF APPLICATION
  • Diabetes mellitus – use of transgenic technology to study both the pathophysiological mechanisms of the disease and new therapies by F. Bosch, Spain
  • The obese gene: an invaluable chance to explore the mechanisms which regulate body weight by M. Maffei, Italy
  • -Cystic Fibrosis – an example of modelling a monogenic disease in the mouse by J. Dorin, United Kingdom
  • -Lessons from the Rb mutant mouse by T. Jacks, United States
  • The use of transgenic, knock-out and interspecific hybrid mice in studies of cancer predisposition and tumour progression by A. Balmain, United Kingdom
  • Oncogene function in normal development and disease by E. Wagner, Austria
  • -The construction and use of HIV-1 transgenic mice in AIDS research by M. Martin, United States
  • Insights into the ontogeny and activation of T cells in mutant mice by T.W. Mak, Canada
  • -Targeted deficiency in the mouse HOXD complex: compound digit defects as a model for the human synpolydactyly syndrome by D. Duboule, Switzerland
  • Transgenic mouse models for skeletal diseases (including osteoporosis and osteoarthritis) by E. Vuorio, Finland
  • -An experiment-based classification of blood pressure genes by J. Krege, United States
  • The use of transgenic mice in the investigation of transmissible Spongiform Encephalopathies by C. Weissmann, Switzerland
  • Transgenic animal models of Alzheimer’s disease pathology by B. Cordell, United States
  • -Transgenic mouse models for Alzheimer’s disease by F. van Leuven, Belgium
  • -Skeletal myogenesis: from determination to therapy G. Cossu, Italy
  • Vaccine development and testing: review by M. De Wilde, Belgium
  • The transgenic mouse model of poliovirus by P. Minor, United Kingdom
  • POLICY ASPECTS AND DISCUSSION
  • -Cryopreservation centres: the means to an archive by L. Mobraaten, United States
  • Towards a central repository of data on transgenic animals and targeted mutations by A. Anagnostopoulos, United States
  • -Drug testing, quality control, and standards by J. Purves, United KingdomGENERAL DISCUSSION SESSION II: FIELDS OF APPLICATION and POLICY ASPECTS AND DISCUSSION
  • Transgenic models in drug discovery - an industrial perspective by P. Hardy, France
  • -Intellectual property aspects by K. Becker, Switzerland
  • PANEL DISCUSSION (SESSION III) AND CONCLUSIONS
  • ANNEX: FOLLOW-UP REGARDING INTELLECTUAL PROPERTY
  • LIST OF PARTICIPANTS

Ejemplares similares